206 related articles for article (PubMed ID: 2420809)
1. Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor.
Benitz WE; Lessler DS; Coulson JD; Bernfield M
J Cell Physiol; 1986 Apr; 127(1):1-7. PubMed ID: 2420809
[TBL] [Abstract][Full Text] [Related]
2. Effect of heparin on vascular smooth muscle cells. II. Specific protein synthesis.
Cochran DL; Castellot JJ; Karnovsky MJ
J Cell Physiol; 1985 Jul; 124(1):29-36. PubMed ID: 2413048
[TBL] [Abstract][Full Text] [Related]
3. Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. I. Evidence for reversible binding and inactivation of the platelet-derived growth factor by heparin.
Fager G; Camejo G; Bondjers G
In Vitro Cell Dev Biol; 1992 Mar; 28A(3 Pt 1):168-75. PubMed ID: 1582991
[TBL] [Abstract][Full Text] [Related]
4. Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro.
Fager G; Hansson GK; Ottosson P; Dahllöf B; Bondjers G
Exp Cell Res; 1988 Jun; 176(2):319-35. PubMed ID: 2837401
[TBL] [Abstract][Full Text] [Related]
5. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth.
Castellot JJ; Addonizio ML; Rosenberg R; Karnovsky MJ
J Cell Biol; 1981 Aug; 90(2):372-9. PubMed ID: 7287812
[TBL] [Abstract][Full Text] [Related]
6. Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth.
Dodge AB; Lu X; D'Amore PA
J Cell Biochem; 1993 Sep; 53(1):21-31. PubMed ID: 8227180
[TBL] [Abstract][Full Text] [Related]
7. Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation.
Benitz WE; Kelley RT; Anderson CM; Lorant DE; Bernfield M
Am J Respir Cell Mol Biol; 1990 Jan; 2(1):13-24. PubMed ID: 2137707
[TBL] [Abstract][Full Text] [Related]
8. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM
Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor (PDGF) accelerates induction of competence, and heparin does not inhibit PDGF-induced competence in primary cultured smooth muscle cells of rat aorta.
Kimura I; Naitoh T; Okabe M; Kimura M
Jpn J Pharmacol; 1992 May; 59(1):51-6. PubMed ID: 1507657
[TBL] [Abstract][Full Text] [Related]
10. Growth factors increase pericellular proteoglycans independently of their mitogenic effects on A10 rat vascular smooth muscle cells.
Emoto N; Onose H; Yamada H; Minami S; Tsushima T; Wakabayashi I
Int J Biochem Cell Biol; 1998 Jan; 30(1):47-54. PubMed ID: 9597753
[TBL] [Abstract][Full Text] [Related]
11. Proteoglycans and vascular cell proliferation.
Wight TN; Potter-Perigo S; Aulinskas T
Am Rev Respir Dis; 1989 Oct; 140(4):1132-5. PubMed ID: 2508521
[TBL] [Abstract][Full Text] [Related]
12. Effects of heparin on growth factor-induced mitogenic and proliferative responses of rat pulmonary artery smooth muscle cells.
Wang HL; Kilfeather SA; Martin GR; Page CP
Zhongguo Yao Li Xue Bao; 1997 Sep; 18(5):397-400. PubMed ID: 10322925
[TBL] [Abstract][Full Text] [Related]
13. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
[TBL] [Abstract][Full Text] [Related]
14. Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity.
Religa P; Kazi M; Thyberg J; Gaciong Z; Swedenborg J; Hedin U
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):419-26. PubMed ID: 11112459
[TBL] [Abstract][Full Text] [Related]
15. Sodium spirulan as a potent inhibitor of arterial smooth muscle cell proliferation in vitro.
Kaji T; Okabe M; Shimada S; Yamamoto C; Fujiwara Y; Lee JB; Hayashi T
Life Sci; 2004 Mar; 74(19):2431-9. PubMed ID: 14998720
[TBL] [Abstract][Full Text] [Related]
16. The antimitogenic action of the sulphated polysaccharide fucoidan differs from heparin in human vascular smooth muscle cells.
Patel MK; Mulloy B; Gallagher KL; O'Brien L; Hughes AD
Thromb Haemost; 2002 Jan; 87(1):149-54. PubMed ID: 11848445
[TBL] [Abstract][Full Text] [Related]
17. Regulation of granulosa cell proliferation: facilitative roles of platelet-derived growth factor and low density lipoprotein.
May JV; Frost JP; Bridge AJ
Endocrinology; 1990 Jun; 126(6):2896-905. PubMed ID: 2351101
[TBL] [Abstract][Full Text] [Related]
18. Aging and arteriosclerosis. The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity.
McCaffrey TA; Nicholson AC; Szabo PE; Weksler ME; Weksler BB
J Exp Med; 1988 Jan; 167(1):163-74. PubMed ID: 3335829
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cultured bovine aortic endothelial cell proliferation by sodium spirulan, a new sulfated polysaccharide isolated from Spirulina platensis.
Kaji T; Fujiwara Y; Hamada C; Yamamoto C; Shimada S; Lee JB; Hayashi T
Planta Med; 2002 Jun; 68(6):505-9. PubMed ID: 12094292
[TBL] [Abstract][Full Text] [Related]
20. Release of endothelial cell-derived growth factor (ECDGF) by heparin.
Gajdusek CM
J Cell Physiol; 1984 Oct; 121(1):13-21. PubMed ID: 6480707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
